Oncology Central is part of Taylor & Francis Group.
Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.
Follow us on social media
Trial watch – antibody-drug conjugates in cancer therapy
Trial Watch – bispecific T cell engagers and higher-order multispecific immunotherapeutics
NKT cells: a generalist in disease treatment and a new key to...
Plain language summary of the management of certain side effects of teclistamab...
Number needed to treat to avoid progression and death and cost analysis:...
Managing side effects of talquetamab for relapsed/ refractory multiple myeloma: a plain...
The prognostic significance of lymph node metastases characteristics in papillary thyroid carcinoma:...
A plain language summary of the CEPHEUS study: D-VRd for newly diagnosed...
PYNNACLE Phase II clinical trial protocol: rezatapopt monotherapy for advanced or metastatic...